Cheryl A Luis
Overview
Explore the profile of Cheryl A Luis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keegan A, Stough C, Paris D, Luis C, Abdullah L, Ait-Ghezala G, et al.
Neurol Res
. 2023 Dec;
46(3):253-260.
PMID: 38095353
Objectives: It has been shown that peripheral measures of brain-derived neurotrophic factor (BNDF), an important neurotrophin instrumental to the biology of learning, may contribute to predicting cognitive decline. However, the...
2.
Keegan A, Stough C, Paris D, Luis C, Abdullah L, Ait-Ghezala G, et al.
J Clin Transl Res
. 2023 Apr;
9(1):50-58.
PMID: 37032999
Background And Aim: is an Ayurvedic herb that has been used for multiple conditions, most notably to augment cognition, particularly memory and attention. Multiple mechanisms, including raising brain-derived neurotrophic factor...
3.
Keegan A, Paris D, Luis C, Abdullah L, Ait-Ghezala G, Beaulieu-Abdelahad D, et al.
Int J Geriatr Psychiatry
. 2017 Jun;
33(2):358-363.
PMID: 28639714
Objective: Detection of Alzheimer's disease (AD) prior to clinical inception will be paramount for introducing disease modifying treatments. We have begun collecting baseline characteristics of a community cohort for longitudinal...
4.
Reckess G, Brandt J, Luis C, Zandi P, Martin B, Breitner J
J Alzheimers Dis
. 2013 May;
36(3):433-43.
PMID: 23645097
Compared with in-person assessment methods, telephone screening for dementia and other cognitive syndromes may improve efficiency of large population studies or prevention trials. We used data from the Alzheimer's Disease...
5.
Luis C, Abdullah L, Ait-Ghezala G, Mouzon B, Keegan A, Crawford F, et al.
Int J Alzheimers Dis
. 2011 Jun;
2011:786264.
PMID: 21660215
We examined the usefulness of brief neuropsychological tests and serum Aβ as a predictive test for detecting MCI/AD in older adults. Serum Aβ levels were measured from 208 subjects who...
6.
Kennelly S, Abdullah L, Kenny R, Mathura V, Luis C, Mouzon B, et al.
Int J Geriatr Psychiatry
. 2011 May;
27(4):415-22.
PMID: 21560164
Background: Evidence suggests that dihydropyridine calcium channel blockers may be useful in preventing and treating Alzheimer's disease (AD). Objective: In an open-label trial of safety and tolerability of nilvadipine in...
7.
Luis C, Abdullah L, Paris D, Quadros A, Mullan M, Mouzon B, et al.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
. 2008 Oct;
16(2):203-18.
PMID: 18923961
Aims: Evidence suggests a relationship between peripheral Abeta and AD. We hypothesized that higher levels of serum Abeta(1-42) would be associated with memory impairment, thought to occur early in the...
8.
Luis C, Keegan A, Mullan M
Int J Geriatr Psychiatry
. 2008 Oct;
24(2):197-201.
PMID: 18850670
Objective: Cross validation study of the MoCA for the detection of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) in a community-based cohort residing in the Southeastern United States. Methods:...
9.
Ait-Ghezala G, Abdullah L, Volmar C, Paris D, Luis C, Quadros A, et al.
Cytokine
. 2008 Oct;
44(2):283-7.
PMID: 18835787
A continuous inflammatory state is associated with Alzheimer's disease (AD) evidenced by an increase in proinflammatory cytokines around beta-amyloid (Abeta) deposits. In addition, functional loss of CD40L is shown to...
10.
Vanderploeg R, Curtiss G, Luis C, Salazar A
J Clin Exp Neuropsychol
. 2007 Aug;
29(6):585-98.
PMID: 17691031
The objective of this study was to examine the prevalence of long-term psychiatric, neurologic, and psychosocial morbidities of self-reported mild traumatic brain injury (MTBI). A cross-sectional cohort sample of three...